Neurology News

Constipation is a relatively common problem in pediatric practice, with reported prevalence rates between 1% and 30%, as well as the chief complaint in 3% to 5% of visits to pediatric outpatient clinics. Because most constipation cases can be remedied through recommended over-the-counter laxatives, constipation is rarely a cause for severe worry among parents.

The FDA has approved a two-part combination therapy in 65 mg capsules to treat adults with late-onset Pompe disease who weigh at least 40 kg and are not improving on their current enzyme replacement regimen.

A Boston-area biotechnology firm announced it has received a patent titled “Carboxylated Psilocybin Derivatives and Methods of Using” for its EVM301 series of molecules to treat a range of mental health disorders.

The FDA’s Cellular, Tissue and Gene Therapies Advisory Committee has voted to deny a biologics license application for NurOwn, an investigational mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis.

An Illinois-based neuro tech company has announced the reception of a multimillion-dollar grant to support a post-stroke recovery study at the Cleveland Clinic with its novel micro-neuromodulation platform.

Identifying your personal and organizational values and building a community are all strategies to develop vitality in careers in medicine, according to a speaker at the Women in Medicine Summit.

PHILADELPHIA — Patients who availed themselves of specialized care for neurofibromatosis received more guideline-concordant care than other patients, with differences found along racial and economic lines, per a poster presentation.

PHILADELPHIA — In older adults, the presence of white and gray matter abnormalities on MRI is linked to greater risk for late-onset epilepsy, according to a poster presentation.

A small study of patients with treatment-resistant depression identified a brain-based biomarker of recovery following deep brain stimulation of the subcallosal cingulate.

PHILADELPHIA — Language training, communication among patients, caregivers and clinicians, and limited treatment wait times are needed for those with limited language proficiency to receive required neurological care, according to a poster.